SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development.

Fuller, SS; Clarke, E; Harding-Esch, EM (2021) Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development. PLoS One, 16 (11). e0259593. ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0259593
SGUL Authors: Harding-Esch, Emma Michele Fuller, Sebastian Suarez

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (903kB) | Preview
[img] Microsoft Word (.docx) (S1 Table) Published Version
Available under License Creative Commons Attribution.

Download (20kB)
[img] Microsoft Word (.docx) (S2 Table) Published Version
Available under License Creative Commons Attribution.

Download (36kB)
[img] Microsoft Word (.docx) (S3 Table) Published Version
Available under License Creative Commons Attribution.

Download (35kB)
[img] Microsoft Word (.docx) (S4 Table) Published Version
Available under License Creative Commons Attribution.

Download (29kB)
[img] Microsoft Word (.docx) (S5 Table) Published Version
Available under License Creative Commons Attribution.

Download (28kB)
[img] Microsoft Word (.docx) (S6 Table) Published Version
Available under License Creative Commons Attribution.

Download (28kB)
[img] Microsoft Word (.docx) (S7 Table) Published Version
Available under License Creative Commons Attribution.

Download (27kB)
[img] Microsoft Word (.docx) (S8 Table) Published Version
Available under License Creative Commons Attribution.

Download (28kB)
[img] Microsoft Word (.docx) (S9 Table) Published Version
Available under License Creative Commons Attribution.

Download (28kB)

Abstract

BACKGROUND: Sexually Transmitted Infections, including Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), continue to be a global health problem. Increased access to point-of-care-tests (POCTs) could help detect infection and lead to appropriate management of cases and contacts, reducing transmission and development of reproductive health sequelae. Yet diagnostics with good clinical effectiveness evidence can fail to be implemented into routine care. Here we assess values beyond clinical effectiveness for molecular CT/NG POCTs implemented across diverse routine practice settings. METHODS: We conducted a systematic review of peer-reviewed primary research and conference abstract publications in Medline and Embase reporting on molecular CT/NG POCT implementation in routine clinical practice until 16th February 2021. Results were extracted into EndNote software and initially screened by title and abstract by one author according to the inclusion and exclusion criteria. Articles that met the criteria, or were unclear, were included for full-text assessment by all authors. Results were synthesised to assess the tests against guidance criteria and develop a CT/NG POCT value proposition for multiple stakeholders and settings. FINDINGS: The systematic review search returned 440 articles; 28 were included overall. The Cepheid CT/NG GeneXpert was the only molecular CT/NG POCT implemented and evaluated in routine practice. It did not fulfil all test guidance criteria, however, studies of test implementation showed multiple values for test use across various healthcare settings and locations. Our value proposition highlights that the majority of values are setting-specific. Sexual health services and outreach services have the least overlap, with General Practice and other non-sexual health specialist services serving as a "bridge" between the two. CONCLUSIONS: Those wishing to improve CT/NG diagnosis should be supported to identify the values most relevant to their settings and context, and prioritise implementation of tests that are most closely aligned with those values.

Item Type: Article
Additional Information: Copyright: © 2021 Fuller et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Chlamydia trachomatis, Gonorrhea, Humans, Point-of-Care Testing, Humans, Chlamydia trachomatis, Gonorrhea, Point-of-Care Testing, General Science & Technology, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: PLoS One
ISSN: 1932-6203
Language: eng
Dates:
DateEvent
8 November 2021Published
21 October 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 34748579
Web of Science ID: WOS:000755468000039
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114183
Publisher's version: https://doi.org/10.1371/journal.pone.0259593

Actions (login required)

Edit Item Edit Item